Publisher： Bentham Science Publishers
E-ISSN： 1875-628x|14|11|1277-1282
ISSN： 1570-1808
Source： Letters in Drug Design & Discovery, Vol.14, Iss.11, 2017-10, pp. : 1277-1282
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
The Changing Face of HDAC Inhibitor Depsipeptide
Current Cancer Drug Targets, Vol. 9, Iss. 1, 2009-02 ,pp. :
Teratogenic Activity of HDAC Inhibitors
Current Pharmaceutical Design, Vol. 20, Iss. 34, 2014-10 ,pp. :
Curcumin: A Natural Pan-HDAC Inhibitor in Cancer
Current Pharmaceutical Design, Vol. 24, Iss. 2, 2018-04 ,pp. :
Progress of HDAC Inhibitor Panobinostat in the Treatment of Cancer
Current Drug Targets, Vol. 15, Iss. 6, 2014-06 ,pp. :